VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Gross profit, 2025
- $10.4B
- YoY, 2025
- +9.1%
- 5-year CAGR
- +13.6%
- 10-year CAGR
- +27.5%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $10.4B | +9.1% |
| 2024 | $9.5B | +10.3% |
| 2023 | $8.6B | +9.6% |
| 2022 | $7.9B | +17.7% |
| 2021 | $6.7B | +22.0% |
| 2020 | $5.5B | +51.3% |
| 2019 | $3.6B | +37.0% |
| 2018 | $2.6B | +19.2% |
| 2017 | $2.2B | +48.4% |
| 2016 | $1.5B | +63.0% |
| 2015 | $915M | +69.3% |
| 2014 | $541M | −51.9% |
| 2013 | $1.1B | −13.0% |
| 2012 | $1.3B | −4.2% |
| 2011 | $1.3B | +839.5% |
| 2010 | $143M | — |